Search research articles
Contact Us
Filters
Showing results (241-250 of 306) with videos related to
Page
of 31
Sort By:
Alimentary Pharmacology & Therapeutics
|
August 25, 2017
Rifaximin treatment is associated with reduced risk of cirrhotic complications and prolonged overall survival in patients experiencing hepatic encephalopathy
S H Kang, Y B Lee, J-H Lee, et al.
International Journal of Obesity (2005)
|
November 28, 2013
Levels of 4-1BB transcripts and soluble 4-1BB protein are elevated in the adipose tissue of human obese subjects and are associated with inflammatory and metabolic parameters
T H Tu, C-S Kim, J-H Kang, et al.
Bone Marrow Transplantation
|
March 26, 2014
PBSC vs BM grafts with myeloablative conditioning for unrelated donor transplantation in adults with high-risk ALL
S-H Shin, J-H Yoon, S-A Yahng, et al.
Bone Marrow Transplantation
|
August 12, 2014
Identification of molecular and cytogenetic risk factors for unfavorable core-binding factor-positive adult AML with post-remission treatment outcome analysis including transplantation
J-H Yoon, H-J Kim, J-W Kim, et al.
Bone Marrow Transplantation
|
June 28, 2016
Comparable outcomes between younger (⩽40 years) and older (>40 years) adult patients with severe aplastic anemia after HLA-matched sibling stem cell transplantation using fludarabine-based conditioning
S H Shin, Y W Jeon, J H Yoon, et al.
Bone Marrow Transplantation
|
November 7, 2012
Survival benefits with transplantation in secondary AML evolving from myelodysplastic syndrome with hypomethylating treatment failure
S-H Shin, S-A Yahng, J-H Yoon, et al.
Leukemia
|
June 19, 2012
Impact of minimal residual disease kinetics during imatinib-based treatment on transplantation outcome in Philadelphia chromosome-positive acute lymphoblastic leukemia
S Lee, D-W Kim, B-S Cho, et al.
Bone Marrow Transplantation
|
July 30, 2013
Experiences of t-PA use in moderate-to-severe hepatic veno-occlusive disease after hematopoietic SCT: is it still reasonable to use t-PA?
J-H Yoon, W-S Min, H-Je Kim, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 9, 2016
Minimal residual disease-based effect and long-term outcome of first-line dasatinib combined with chemotherapy for adult Philadelphia chromosome-positive acute lymphoblastic leukemia
J-H Yoon, H-Y Yhim, J-Y Kwak, et al.
Bone Marrow Transplantation
|
September 25, 2012
Risk and prognostic factors for acute GVHD based on NIH consensus criteria
S-E Lee, B-S Cho, J-H Kim, et al.
Page
of 31
Search research articles
Search
Showing results (241-250 of 306) with videos related to
Sort By:
Page
of 31
Alimentary Pharmacology & Therapeutics
|
August 25, 2017
Rifaximin treatment is associated with reduced risk of cirrhotic complications and prolonged overall survival in patients experiencing hepatic encephalopathy
S H Kang, Y B Lee, J-H Lee, et al.
International Journal of Obesity (2005)
|
November 28, 2013
Levels of 4-1BB transcripts and soluble 4-1BB protein are elevated in the adipose tissue of human obese subjects and are associated with inflammatory and metabolic parameters
T H Tu, C-S Kim, J-H Kang, et al.
Bone Marrow Transplantation
|
March 26, 2014
PBSC vs BM grafts with myeloablative conditioning for unrelated donor transplantation in adults with high-risk ALL
S-H Shin, J-H Yoon, S-A Yahng, et al.
Bone Marrow Transplantation
|
August 12, 2014
Identification of molecular and cytogenetic risk factors for unfavorable core-binding factor-positive adult AML with post-remission treatment outcome analysis including transplantation
J-H Yoon, H-J Kim, J-W Kim, et al.
Bone Marrow Transplantation
|
June 28, 2016
Comparable outcomes between younger (⩽40 years) and older (>40 years) adult patients with severe aplastic anemia after HLA-matched sibling stem cell transplantation using fludarabine-based conditioning
S H Shin, Y W Jeon, J H Yoon, et al.
Bone Marrow Transplantation
|
November 7, 2012
Survival benefits with transplantation in secondary AML evolving from myelodysplastic syndrome with hypomethylating treatment failure
S-H Shin, S-A Yahng, J-H Yoon, et al.
Leukemia
|
June 19, 2012
Impact of minimal residual disease kinetics during imatinib-based treatment on transplantation outcome in Philadelphia chromosome-positive acute lymphoblastic leukemia
S Lee, D-W Kim, B-S Cho, et al.
Bone Marrow Transplantation
|
July 30, 2013
Experiences of t-PA use in moderate-to-severe hepatic veno-occlusive disease after hematopoietic SCT: is it still reasonable to use t-PA?
J-H Yoon, W-S Min, H-Je Kim, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 9, 2016
Minimal residual disease-based effect and long-term outcome of first-line dasatinib combined with chemotherapy for adult Philadelphia chromosome-positive acute lymphoblastic leukemia
J-H Yoon, H-Y Yhim, J-Y Kwak, et al.
Bone Marrow Transplantation
|
September 25, 2012
Risk and prognostic factors for acute GVHD based on NIH consensus criteria
S-E Lee, B-S Cho, J-H Kim, et al.
Page
of 31